Acutus Medical, Inc. AFIB OTC

Acutus Medical, Inc. (AFIB) generated $-4.06M in operating cash flow for quarter ending 2024-12-31. After capital expenditures of $36K, free cash flow was $-4.02M.

Free cash flow margin was -56.3% of revenue. Cash conversion ratio was 3.1x, indicating earnings are backed by cash.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (15/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (10/100) — Cash conversion ratio was 3.1x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 45/100 with 2/7 criteria passed.